Cargando...
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22(+)IL-17(−)IL-13(+) T cells is significantly increased in peripheral blood...
Gardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485827/ https://ncbi.nlm.nih.gov/pubmed/26155400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005460 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|